| |
| |
SPOT ON
|
 |
Manipulated data in the STOP-NIDDM trial on acarbose
COMET: Carvedilol vs metoprolol in heart failure
|
| |
| |
NEW ON THE MARKET
|
| |
Transdermal contraception with EVRA |
| |
| |
BEWARE! MISINFORMATION
|
| |
Atorvastatin (SORTIS) and the ASCOT trial
|
| |
| |
a-t READERS' QUESTIONS AND COMMENTS
|
| |
Candesartan (e.g. ATACAND) for prophylaxis of migraine headaches?
Pfizer argues against generic preparations of gabapentin
Buprenorphine TDS compatible with opioids?
VIANI promotional material as hazardous waste
|
| |
| |
IN BRIEF
|
| |
Expired drugs ineffective or dangerous?
Migraine: Ergotamine now 700% more expensive
Raloxifene (e.g. EVISTA) lowering levothyroxine levels
Warning sheet for the wallet: Antimalarial mefloquine (LARIAM) and neuropsychic symptoms
|
| |
| |
CURRENT ADR NETWORK REPORT
|
| |
Renal failure due to COX-2 inhibitors
Hypersensitivity reaction triggered by ezetimibe (EZETROL)
|
| |
| |
SIDE EFFECTS
|
| |
Antimalarial MALARONE: Suicidality and severe skin reactions
Fatalities under growth hormone (GENOTROPIN)
Hormone replacement therapy and breast cancer mortality
|
| |